CSIMarket Company Name, Ticker, Customers, else..
 
Avita Medical Inc   (RCEL)
Other Ticker:  
 
 
Price: $9.7000 $0.13 1.358%
Day's High: $9.77 Week Perf: 9.73 %
Day's Low: $ 9.38 30 Day Perf: 0.94 %
Volume (M): 93 52 Wk High: $ 18.93
Volume (M$): $ 899 52 Wk Avg: $11.75
Open: $9.60 52 Wk Low: $7.51



 Market Capitalization (Millions $) 246
 Shares Outstanding (Millions) 25
 Employees -
 Revenues (TTM) (Millions $) 45
 Net Income (TTM) (Millions $) -34
 Cash Flow (TTM) (Millions $) 9
 Capital Exp. (TTM) (Millions $) 1

Avita Medical Inc
Avita Medical Inc is a global regenerative medicine company that specializes in the development and commercialization of advanced therapeutic solutions for skin regeneration. The company is known for its innovative technology called ReCell, which enables medical professionals to rapidly and efficiently create a suspension of individual skin cells for use in the treatment of severe burns, chronic wounds, and other skin defects. Avita Medical focuses on improving patient outcomes and quality of life by providing personalized and regenerative treatments that enhance the natural healing process of the body. The company operates with a commitment to delivering advancements in healing and aesthetics through its cutting-edge products and therapies.


   Company Address: 28159 Avenue Stanford Valencia 91355 CA
   Company Phone Number: 367-9170   Stock Exchange / Ticker: NASDAQ RCEL


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Contract

AVITA Medical Innovates Wound Care with Exclusive Collagen Dermal Matrix Partnership

Published Wed, Jul 31 2024 8:05 PM UTC

In a significant move aimed at enhancing wound care solutions, AVITA Medical has announced the expansion of its product portfolio through an exclusive development and distribution agreement with Regenity Biosciences. This partnership will enable AVITA Medical to introduce a new collagen dermal matrix, a novel technology designed to optimize healing for patients with a variet...
Product Service News

AVITA Medical Sets New Benchmark with RECELL GO?s Successful Implementation at Joseph M. Still Burn Center

Published Wed, Jun 5 2024 8:25 PM UTC

In a groundbreaking development, AVITA Medical, a renowned regenerative medicine company, recently achieved a significant milestone by successfully treating their first patient using the FDA-approved RECELL GO System. This noteworthy feat took place at the Joseph M. Still Burn Center, located at Doctors Hospital of Augusta. The successful application of AVITA's cutting-edge ...
Product Service News

AVITA Medical Advances RECELL GO PMA Supplement Review Following FDA Clarification

Published Thu, Feb 29 2024 9:02 PM UTC

AVITA Medical, a global regenerative medicine company, has recently submitted a response to the U.S. Food and Drug Administration (FDA), providing additional information in relation to its RECELL GO Premarket Approval (PMA) supplement. This submission marks an important milestone for the company, as it signifies the resumption of the substantive review process by the FDA. AV...
Avita Medical Inc

Avita Medical Inc Experiences Surge in Fiscal Third Quarter 2023 Deficit, Outpacing Previous Year, at the Medical Equipment & Supplies Company

Avita Medical Inc is a medical technology company specializing in regenerative medicine solutions for the treatment of wounds and skin defects. The company focuses on developing and commercializing innovative products that harness the body's natural healing process to restore damaged skin and tissue.
In the fiscal third quarter of 2023, Avita Medical Inc experienced diminishing returns, with a loss of $0.34 per share compared to a loss of $0.22 per share in the same period the year before. However, there was improvement in earnings per share (EPS) from the prior reporting period, with a loss of $0.41 per share. This indicates that although the company's financial performance did not meet expectations, there was some progress in reducing losses.
Avita Medical Inc

Despite Surge in Revenue, Avita Medical Inc Fails to Achieve Profitability in the Second Quarter of 2023


Introduction
In the second quarter of 2023, Avita Medical Inc, a prominent Medical Equipment & Supplies company, experienced a substantial increase in revenue but also witnessed an amplified loss per share compared to the previous reporting periods. While the revenue surge of 41.008% to $11.75 million is an optimistic sign, it raises questions about the company's profitability and long-term sustainability. This article delves into the financial performance of Avita Medical Inc, highlighting key facts and potential implications for investors.
Revenue Growth Amid Rising Losses
Avita Medical Inc's revenue for the financial second quarter of 2023 displayed a remarkable upswing, jumping by 41.008% from $10.55 million to $11.75 million compared to the same reporting period a year earlier. This surge in revenue is indeed an impressive achievement, potentially signifying increased market demand for the company's medical equipment and supplies.






Avita Medical Inc's Segments





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com